The effects of combination-therapy of tocilizumab and baricitinib on the management of severe COVID-19 cases: a randomized open-label clinical trial

• Glavni autori: Farzaneh Dastan (Autor), Hamidreza Jamaati (Autor), Saghar Barati (Autor), Shahrzad Varmazyar (Autor), Sahar Yousefian (Autor), Elmira Niknami (Autor), Payam Tabarsi (Autor)
• Format: Knjiga
• Izdano: Frontiers Media S.A., 2023-10-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Background: Tocilizumab and baricitinib are considered standard treatments for hospitalized COVID-19 patients with an inflammatory status. However, the effects of co-administering these medications aiming for more rapid patient recovery are controversial among practitioners. The potential benefits i...